Zyrik 300 (10 Tablet)

Zyrik 300 (10 Tablet)

Prescription requiredRx Required

Salt Composition: Allopurinol (300mg)

Expiry Date: 01/2028

Special offer

Price on Request

Price on Request

Inclusive of all taxes

10 Tablet

About The Product

it forms crystals that can appear around your joints and kidneys and cause pain. This medicine helps to keep uric acid levels low.

Description

Zyrik 300 Tablet contains Allopurinol as an active ingredient which is a xanthine oxidase inhibitor. This medicine is used to prescribe to treat and prevent gout. A high level of uric acid in the body may result in gout that can cause pain by forming crystals around the kidneys and joints.


This medication helps in keeping low uric acid levels. It works by blocking the action of enzyme responsible for uric acid formation. It should be taken with food in dose and duration as advice by the doctor. Don't take more than the recommended dose.


Uses

  • Treatment of Gout

Side Effects

Side effects are unwanted symptoms that can occur from any medical treatment. Like other medications, the Zyrik 300 Tablet can also have adverse effects on the body, most of which resolve without the need for medical attention.
Some common side effects include:

  • Diarrhea
  • Elevated serum glutamic oxaloacetic transaminase
  • Elevated serum glutamic pyruvic transaminase
  • Increased alkaline phosphatase level in blood

Seek medical attention in case of any unusual or severe side effects immediately.

How To Use

  • Doctor determines the exact dose and duration with Zyrik 300 Tablet as per the overall health condition of the patient.
  • This tablet should be taken with food or after food, but at the fix time every day to get effective results.
  • Don't miss a dose or overdose on the medicine.
  • Swallow it as a whole with a glass of water and do not crush, chew, or open it.

How It Works

Zyrik 300 Tablet contains Allopurinol as an active ingredient which is a xanthine oxidase inhibitor.

It works by blocking the action of enzyme responsible for uric acid formation and preventing future attacks rather than treating acute or active pain.

Safety Advice

Alcohol
Avoid the consumption of alcohol while taking Zyrik 300 Tablet, as alcohol can decrease the effectiveness of the medicine as well as worsen the symptoms.
Pregnancy
Do not take Zyrik 300 Tablet without consulting the doctor in case of pregnancy, as it can be unsafe to take it during this period.
Breast Feeding
Breastfeeding women should discuss the potential risks and benefits of the Zyrik 300 Tablet with their healthcare provider before starting treatment.
Driving
Zyrik 300 Tablet may cause side effects such as dizziness or lack of concentration, which could affect your ability to drive. So it's better to avoid driving.
Kidney
Share your medical history with the doctor before starting the Zyrik 300 Tablet. Do not take it without consulting a doctor if you have any kidney related issue.
Liver
Share your medical history with the doctor before starting the Zyrik 300 Tablet. Do not take it without consulting a doctor if you have any liver related issue.

FAQs

This medicine is used to prescribe to treat and prevent gout.

References

  • Vargas-Santos, A. B., Peloquin, C. E., Zhang, Y., & Neogi, T. (2018). Association of chronic kidney disease with allopurinol use in gout treatment. JAMA internal medicine, 178(11), 1526-1533. https://pubmed.ncbi.nlm.nih.gov/30304329/
  • Agarwal, V., Hans, N., & Messerli, F. H. (2013). Effect of allopurinol on blood pressure: a systematic review and meta‐analysis. The Journal of Clinical Hypertension, 15(6), 435-442. https://pubmed.ncbi.nlm.nih.gov/23730993/
  • Stamp, L. K., Taylor, W. J., Jones, P. B., Dockerty, J. L., Drake, J., Frampton, C., & Dalbeth, N. (2012). Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol. Arthritis & Rheumatism, 64(8), 2529-2536. https://pubmed.ncbi.nlm.nih.gov/22488501/
  • Hande, K., Reed, E., & Chabner, B. (1978). Allopurinol kinetics. Clinical Pharmacology & Therapeutics, 23(5), 598-605. https://pubmed.ncbi.nlm.nih.gov/639435/
  • Chao, J., & Terkeltaub, R. (2009). A critical reappraisal of allopurinol dosing, safety, and efficacy for hyperuricemia in gout. Current rheumatology reports, 11(2), 135-140. https://pubmed.ncbi.nlm.nih.gov/19296886/
  • Murrell, G. A. C., & Rapeport, W. G. (1986). Clinical pharmacokinetics of allopurinol. Clinical pharmacokinetics, 11(5), 343-353. https://pubmed.ncbi.nlm.nih.gov/3536254/

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Magicine PharmacopyCopyright 2026